NEW YORK (GenomeWeb) – Researchers from the Impact of Personal Genomics (PGen) study have found that nearly 6 percent of customers who use direct-to-consumer personal genetic testing (DTC-PGT) services made changes to their prescription medication based on their test results.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.